Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
PURE PHARMA from Oostkamp, company number BE0550580116, closed financial year 2025 with a result of € -256,645 after tax. For that financial year PURE PHARMA recorded a gross margin of € 369,842 and equity of € 383,549. Compared with financial year 2024, the result moved from € -292,570 to € -256,645. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 383,549
▼ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -256,645
▲ 12 % less loss than in 2024
Profit after tax over the fiscal year.
€ 16,913
▼ 92% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 183,549.
People and assets in 2025
5.5
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 438,642
▲ 2% vs 2024
€ 79,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 84,678
▼ 35% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 416,373
▲ 68% vs 2024
€ 49,575 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 364,074
▲ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 88,593
▲ 56% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,216,175 | € 874,057 | € 658,171 | € 369,842 | ▼ 44% |
| Profit after taxes | € 479,620 | € 284,222 | € -292,570 | € -256,645 | ▲ € 35,925 |
| Equity | € 748,542 | € 932,765 | € 640,194 | € 383,549 | ▼ 40% |
| Total debts | € 1,842,652 | € 1,208,835 | € 1,040,518 | € 1,618,409 | ▲ 56% |
| Cash | € 1,060,854 | € 168,800 | € 219,894 | € 16,913 | ▼ 92% |
| Retained profit | € 548,542 | € 732,765 | € 440,194 | € 183,549 | ▼ 58% |
| Dividend | € 100,000 | € 100,000 | € 0 | € 0 | |
| Bank debt | € 258,460 | € 226,585 | € 248,173 | € 416,373 | ▲ 68% |
| Balance sheet total | € 2,591,195 | € 2,141,600 | € 1,680,712 | € 2,001,957 | ▲ 19% |
| Employees (FTE) | 6.7 | 5.9 | 5.8 | 5.5 | ▼ 0.3 |
Key figures of PURE PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PURE PHARMA?
What happened at PURE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jutho NV stepped down as director. NBB
- Samanco BV stepped down as director. NBB
- Interior Decoration Group NV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 256,645. Source: NBB ↗
- Jutho NV became a director. NBB
- Samanco BV became a director. NBB
- Interior Decoration Group NV became a director. NBB
- New establishment in Oostkamp. KBO
In short
From € 479,620 profit in 2022 to € 256,645 loss in 2025.
Paid € 208,583 in corporate taxes since 2022.
Best year ever: 2022, with € 479,620 profit.
On average € 67,200 of value added per employee in 2025.
A new publication or filing at PURE PHARMA? We notify you, reason included.
Follow PURE PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of INTERIOR DECORATION GROUP, SAMANCO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PURE PHARMAThe shares are held by INTERIOR DECORATION GROUP (67%) and SAMANCO (33%).
Directors
According to the 2025 annual accounts
Managing director · represented by Nathalie Bert
Also active at: Atelier PURE, LANNOO LABELS, DE COENE INTERIOR DECORATION, VERTEAU, INTERIOR DECORATION GROUP, ve'rs interieur
since 2024 · until 2028
Managing director · represented by Angelo Vanhaelewyn
since 2022 · until 2028
Director · represented by Tom Potteau
since 2022 · until 2028
Shareholders
33%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lieverstedestraat 23
8020 Oostkamp
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0550.580.116
- VAT number
- BE 0550.580.116
- Registered office
- Lieverstedestraat 23, 8020 Oostkamp
- Names & denominations
- PURE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 April 2014
- Peppol
- Active · Active since 25 Aug 2025
- Contact
- pure-pharma.be
- Activities · NACE
Algemene bouw van andere niet-residentiële gebouwen
Activiteiten van bouwarchitecten
Algemene bouw van residentiële gebouwen
Activiteiten van interieurarchitecten
Algemene bouw van kantoorgebouwen